Tylenol alert!!
I’ll take a wild stab that Tylenol refused to be shaken down hence the “link” to autism. Lol.
Comments
-
The Throbber was completely underwhelmed at the Tylenol announcement.
Do better, RFKJ.
Remove the liability exemption for vaccines on Big Pharma and require absolute disclosure (like 4 minutes worth) on all pharma advertising.
-
This was actually known / suspected 3 years ago. It is 100% correlated to ADHD in kids, too.
-
known and 100% correlated? interesting choice of words.
-
I had a real laugh out loud reading idiots Trump and Kennedy espousing dangers of venerable Tylenol.
-
I knew at least one trumptard was buying this.
-
Why do you think you ended up autistic? Curiosity, since you’re clearly on that end of the autism spectrum.
-
Buck seems on the spectrum. Soccer dudette is definitely Tourette's.
-
Take it up with UW Medicine, fucktard.
-
This study was very very limited and maybe does a little to just get funding for a broader study.
This work should be considered in the context of several limitations. First, we only included Black/African American women in the Urban South, limiting generalizability, but also enhancing data for a group traditionally underrepresented in research. Second, our sample size was small, particularly for RNA sequencing, which only included 174 placentas. Third, we measured expression using bulk RNA sequencing. Single-cell transcriptomics could additionally capture toxicant-associated changes in the relative abundance and/or impairment of specific cell types78. Fourth, we used a one-time measurement of metabolites in maternal blood during pregnancy to characterize APAP exposure. A single time point measurement is more likely to capture frequent compared with sporadic users, and APAP use during one time point could correlate with use at other time points in pregnancy. Thus, our results should not be interpreted as pinpointing the second trimester as a window of high susceptibility. The literature suggests that the third trimester may be a more relevant window of APAP susceptibility in relation to neurodevelopment12,13. This could be a consequence of the peak brain growth spurt that occurs in the third trimester79, or because APAP used by the mother during the immediate pre-partum period may be left to newborns with underdeveloped capacities to metabolize it80. Additionally, the prevalence of individuals with APAP biomarkers detected in our study probably underestimates the prevalence of APAP use throughout all of pregnancy. Finally, while we adjusted for multiple potential sources of confounding, unobserved confounding is always possible in observational epidemiologic studies.
…. So they basically just come out and admit it, "not be interpreted as"… conclusive.
-
It doesn't look like whoever wrote that article even went to the limitations section. Those sections are in most scientific papers.




